Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana

Abstract Background To investigate the prevalence and factors associated with the prevalence of multidrug/rifampicin-resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana. Methods A retrospective review of medical records of suspected drug resistant tuberculosis pat...

Full description

Bibliographic Details
Main Authors: Blackson Pitolo Tembo, Ntambwe Gustav Malangu
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-019-4375-7
_version_ 1819103467040407552
author Blackson Pitolo Tembo
Ntambwe Gustav Malangu
author_facet Blackson Pitolo Tembo
Ntambwe Gustav Malangu
author_sort Blackson Pitolo Tembo
collection DOAJ
description Abstract Background To investigate the prevalence and factors associated with the prevalence of multidrug/rifampicin-resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana. Methods A retrospective review of medical records of suspected drug resistant tuberculosis patients receiving care at public health facilities in Botswana was conducted from January, 2013 and December, 2014. Patient characteristics and drug susceptibility data were abstracted from 2568 medical records on to a pre-tested checklist form. The prevalence of multidrug/rifampicin resistance was computed. Bivariate and multivariate logistic regression was carried out to determine the factors associated with the prevalence of multidrug/rifampicin in the study population. Results Overall, multidrug/ rifampicin - resistance among suspected drug resistant tuberculosis patients in Botswana were found in 139 (5.4%) cases with 1.3% among new cases and 7.7% among previously treated tuberculosis patients. Being a previously treated tuberculosis patient and having a positive smear were found to be factors associated with the prevalence of multidrug/rifampicin-resistant tuberculosis (p < 0.05). However, age, sex, living in urban area and HIV status were not associated with this disease (p > 0.05). Conclusion This study highlights a low burden of multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients receiving care at public health facilities in Botswana. Strategies in controlling MDR/RR-TB should emphasize on effective implementation of Directly Observation Treatment – short course strategy, continuous surveillance of drug resistance cases, prevention of the development of new cases of MDR/RR-TB and to treat existing patients. Further interventions should focus on strengthening TB infection control activities.
first_indexed 2024-12-22T01:50:55Z
format Article
id doaj.art-512cb8aa45194843a31f963949ee8590
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-22T01:50:55Z
publishDate 2019-09-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-512cb8aa45194843a31f963949ee85902022-12-21T18:42:54ZengBMCBMC Infectious Diseases1471-23342019-09-011911810.1186/s12879-019-4375-7Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in BotswanaBlackson Pitolo Tembo0Ntambwe Gustav Malangu1National Tuberculosis Reference Laboratory, Ministry of HealthDepartment of Epidemiology and Biostatistics, Sefako Makgatho Health Sciences UniversityAbstract Background To investigate the prevalence and factors associated with the prevalence of multidrug/rifampicin-resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana. Methods A retrospective review of medical records of suspected drug resistant tuberculosis patients receiving care at public health facilities in Botswana was conducted from January, 2013 and December, 2014. Patient characteristics and drug susceptibility data were abstracted from 2568 medical records on to a pre-tested checklist form. The prevalence of multidrug/rifampicin resistance was computed. Bivariate and multivariate logistic regression was carried out to determine the factors associated with the prevalence of multidrug/rifampicin in the study population. Results Overall, multidrug/ rifampicin - resistance among suspected drug resistant tuberculosis patients in Botswana were found in 139 (5.4%) cases with 1.3% among new cases and 7.7% among previously treated tuberculosis patients. Being a previously treated tuberculosis patient and having a positive smear were found to be factors associated with the prevalence of multidrug/rifampicin-resistant tuberculosis (p < 0.05). However, age, sex, living in urban area and HIV status were not associated with this disease (p > 0.05). Conclusion This study highlights a low burden of multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients receiving care at public health facilities in Botswana. Strategies in controlling MDR/RR-TB should emphasize on effective implementation of Directly Observation Treatment – short course strategy, continuous surveillance of drug resistance cases, prevention of the development of new cases of MDR/RR-TB and to treat existing patients. Further interventions should focus on strengthening TB infection control activities.http://link.springer.com/article/10.1186/s12879-019-4375-7PrevalenceMDR/RR-TBAssociated factorsRetrospective reviewBotswana
spellingShingle Blackson Pitolo Tembo
Ntambwe Gustav Malangu
Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana
BMC Infectious Diseases
Prevalence
MDR/RR-TB
Associated factors
Retrospective review
Botswana
title Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana
title_full Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana
title_fullStr Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana
title_full_unstemmed Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana
title_short Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana
title_sort prevalence and factors associated with multidrug rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in botswana
topic Prevalence
MDR/RR-TB
Associated factors
Retrospective review
Botswana
url http://link.springer.com/article/10.1186/s12879-019-4375-7
work_keys_str_mv AT blacksonpitolotembo prevalenceandfactorsassociatedwithmultidrugrifampicinresistanttuberculosisamongsuspecteddrugresistanttuberculosispatientsinbotswana
AT ntambwegustavmalangu prevalenceandfactorsassociatedwithmultidrugrifampicinresistanttuberculosisamongsuspecteddrugresistanttuberculosispatientsinbotswana